[Analysis of HBV rtS213T mutation during interferon therapy]

Zhonghua Gan Zang Bing Za Zhi. 2010 Mar;18(3):227-8. doi: 10.3760/cma.j.issn.1007-3418.2010.03.018.

[Article in Chinese]

Authors

Wei-Hong Ren¹, Su-Ling Zhao, Zhi-Juan Zhao, Yan-Qing Li, Hui-Qing Tao, Hui Xiong

Affiliation

¹ Department of Clinical Laboratory, the First Affiliated Hospital of Henan College of TCM, Zhengzhou 450000, China. ren_weihong@hotmail.com

PMID: 20380803
DOI: 10.3760/cma.j.issn.1007-3418.2010.03.018

No abstract available

Publication types

Controlled Clinical Trial

MeSH terms

Adolescent
Adult
Aged
Antiviral Agents / therapeutic use
DNA, Viral
Female
Hepatitis B virus / genetics*
Hepatitis B, Chronic / drug therapy
Hepatitis B, Chronic / virology*
Humans
Interferons / therapeutic use
Male
Middle Aged
Mutation
Young Adult

Substances

Antiviral Agents
DNA, Viral
Interferons